{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwJKrsJMLDA","lastupdate":"2021-01-17T00:00:00.000Z","update_date":"2021-01-17T00:00:00.000Z","lastModified":"Mar 25, 2024","active":1,"confidence_score":97,"confidence_score_reason":"video or image, markets","urlname":"protekt-therapeutics","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$PUC7R9TDFPF3OWeavgoDg0BM7Cm0A86pfcVq05rYY1jqIa8S27qERK.png","name":"Protekt Therapeutics ","oneliner":"PKR Inhibition for Treating Neurodegenerative Diseases","registrar":"515168573","website":"https://www.protektx.com/","careerspage":"","founded_month":12,"founded_year":2014,"formernames":["MemoFit"],"sociallinks":{"twitter":"","youtube":"","facebook":"https://www.facebook.com/Protektx","linkedin":"","instagram":""},"social":["https://www.facebook.com/Protektx"],"flattenedsociallinks":"https://www.facebook.com/Protektx","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"1-10","employees_exact":2,"patent":1,"raised":13850000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Protect Therapeutics"],"about":"Protekt Therapeutics is a biopharmaceutical company aiming to identify and develop a potent and selective oral PKR inhibitor (PKRi) to treat cognitive disorders such as Alzheimers disease and mild cognitive impairment. PKR is a stress and proapoptotic kinase that phosphorylates eIF2, a key protein in the translation machinery, and results in inhibition of protein synthesis and impaired memory consolidation.\n\nPKR is also activated during apoptosis, autophagy, neuroinflammation, and A peptide toxicity, which are prominent features of Alzheimer's Disease (AD). Therefore, PKR inhibition offers a novel and promising disease-modifying mechanism for modulating multiple key processes in AD and other neurodegenerative diseases.\n\nProteKt Therapeutics was established in the FutuRx Incubator in December 2015 based on technology from Prof. Kobi Rosenblum's lab (Haifa University) and is now fully owned by Bukwang Pharmaceutical.","climatetech_description":null,"is_climatetech_relevant":null,"phone":null,"country":null,"address":{"israeli":[{"id":"Z6v09SlllGgLoAx5EDh63c3rr0wLzS7sypjo3nvg4h0rdwLkAThMcu","city":"Bnei Brak","type":null,"address":"Bar Kochva St 16, Bnei Brak, Israel","placeid":"ChIJ0yrg3StKHRURAiXsoB63zC8","notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[{"id":"9c1c6eca-3e7a-4ddf-8a1b-f52f0fb98414","date":"Jul 21, 2020","link":"https://www.globes.co.il/news/article.aspx?did=1001336551","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Investment, Alzheimers treatment","company":"ProteKt Therapeutics","layoffs":"N/A","summary":"Israeli company ProteKt Therapeutics is developing a new treatment for Alzheimers disease based on a mechanism called PKR. The company has developed a drug that inhibits the activity of PKR, which is released in the body during stress, and can cause a reduction in protein production in cells. The company has raised $3.6 million in a recent funding round from investors including Fonds de Solidarite and Bukwang Pharmaceutical, bringing its total funding to over $7 million.","partners":"N/A","customers":"N/A","investors":["Fonds de Solidarite","Bukwang Pharmaceutical","OrbiMed","Takeda","Johnson and Johnson","RMGP","Carmel"],"confidence":8,"key_topics":["Alzheimers treatment","PKR mechanism","Investment","Drug development","Animal testing"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"$3.6 million","structured_issues":"Investment","acquisition_amount":"N/A","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LLKJA8lvBcX1VCfBfARr7wYA73AJYi9MQLaqGMiSQLUzL4utPJRhY3","news_summary":"החברה שמצאה מנגנון חדש שעשוי לעכב אלצהיימר","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"aeeeab00-641a-4feb-90dc-4cd8e3a837b6","date":"Feb 6, 2020","link":"https://www.timesofisrael.com/israeli-startup-hopes-to-battle-alzheimers-with-enzyme-busting-drug/?utm_source=Startup+Daily&utm_campaign=startup-daily-2020-02-06&utm_medium=email","source":"www.timesofisrael.com","visible":1,"analysis":{"tags":["drug development"],"company":"ProteKt Therapeutics","layoffs":null,"summary":"Israeli startup ProteKt Therapeutics is developing a drug to treat early stages of Alzheimer’s by targeting an enzyme. The company has raised $3.6 million in funding from investors including Quebec’s Fonds de solidarité FTQ fund and Korean pharma firm Bukwang Pharmaceutical. ProteKt has identified a series of 150 small synthetic compounds that could help inhibit the enzyme and has shown their potential to improve cognition in lab tests. The funding will be used to further develop and improve the most effective molecule and conduct animal testing. ProteKt aims to prove that the compound can enter the brain and plans to undertake clinical trials in the future.","partners":null,"customers":null,"investors":["Quebec’s Fonds de solidarité FTQ fund","Korean pharma firm Bukwang Pharmaceutical","FutuRx","OrbiMed","Johnson & Johnson Innovation – JJDC, Inc.","Takeda Ventures, Inc.","RM Global Partners (RMGP) BioPharma Investment Fund"],"confidence":8,"key_topics":["Alzheimers","enzyme inhibition","neurodegenerative diseases","drug development","investment"],"date_of_event":"November","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$3.6 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"XLf5oFY5AxteIRul7aI4S3vy4MHCe56nZ9id5Ha8jt8NdJAEL2HbxB","news_summary":"Israeli startup hopes to battle Alzheimer's with enzyme-busting drug","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"715dd9d1-3af1-48b6-b93f-a917f6946d21","date":"Nov 13, 2019","link":"https://en.globes.co.il/en/article-israeli-co-protekt-therapeutics-raises-36m-1001307001","source":"en.globes.co.il","visible":1,"analysis":{"tags":"equity financing, neurodegenerative diseases, PKR kinase inhibitor-based therapies","company":"ProteKt Therapeutics","layoffs":null,"summary":"ProteKt Therapeutics, an Israeli biotech company, has signed a binding agreement for a $3.6 million equity financing round. The financing will be used to select a lead drug candidate molecule and validate its neurotherapeutic effects in vivo. The company also plans to initiate the clinical development of a related diagnostic assay for patient selection and treatment personalization. The funding will enable ProteKt Therapeutics to continue the development of novel therapies for neurodegenerative diseases, such as Alzheimers disease. The company aims to adopt a precision medicine approach and develop a patient selection diagnostic assay to increase the likelihood of effective treatment. The equity financing round was co-led by Fonds de Solidarité FTQ and Bukwang Pharmaceutical, along with existing investors FutuRx, OrbiMed, Johnson & Johnson Innovation - JJDC, Inc., Takeda Ventures, Inc., and RM Global Partners (RMGP) BioPharma Investment Fund.","partners":null,"customers":null,"investors":"Fonds de Solidarité FTQ, Bukwang Pharmaceutical, FutuRx, OrbiMed, Johnson & Johnson Innovation - JJDC, Inc., Takeda Ventures, Inc., RM Global Partners (RMGP) BioPharma Investment Fund","confidence":9,"key_topics":["equity financing","neurodegenerative diseases","PKR kinase inhibitor-based therapies","clinical development","precision medicine"],"date_of_event":"November 13, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$3.6 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kbW4pmV4WSmzvDZX6HBkDp9A2w97IPHPQjy74bhfAA86yXfRL5mgff","news_summary":"Israeli co ProteKt Therapeutics raises $3.6m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"07a204b3-75ca-40ff-8767-923df0a7c48a","date":"May 18, 2017","link":"http://www.globes.co.il/en/article-rm-global-to-invest-$30m-in-futurx-biotech-startups-1001189272","source":"www.globes.co.il","visible":1,"analysis":{"tags":["venture capital","investment","biotech","incubator"],"company":"RM Global","layoffs":null,"summary":"US-based international investment bank RM Global is establishing a new venture capital fund that has already closed its first financing round of $30 million and will soon embark on a second financing round. The fund will invest exclusively in companies operating in Israels FutuRx incubator in Ness Ziona near Rehovot. The fund has raised money from financial and strategic investors, and hopes to raise additional tens of millions of dollars.","partners":"OrbiMed Israel Partners, Johnson & Johnson Innovation, Takeda Ventures","customers":null,"investors":"financial and strategic investors","confidence":8,"key_topics":["venture capital fund","FutuRx incubator","investment","biotech","Israel"],"date_of_event":"May 18, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$30 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"c3PHF2vwmLKQNdQXmLik4jRJqS4PRFEzehIrDAcwFyym0sTCBnRJFK","news_summary":"RM Global to invest $30m in FutuRx biotech startups","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"530ed88d-73f4-4aff-b911-99aec0558c24","date":"Dec 15, 2015","link":"http://www.israel21c.org/haifa-team-ids-activity-of-proteins-linked-to-memory-loss/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"brain proteins, memory impairments, Alzheimers disease","company":"University of Haifa","layoffs":null,"summary":"A study by University of Haifa scientists has identified brain proteins associated with memory impairments in Alzheimers disease. The study also found that repairing this activity leads to an improvement in memory. The researchers hope to develop a drug that can delay the onset of cognitive symptoms. The study was published in the Journal of Neuroscience.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["brain proteins","memory impairments","Alzheimers disease","cognitive symptoms","drug development"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xy5BCnpJF0VVtNEps2TsamtSUnsNWPSWv4kMK8yjRwv2hNmykZUvAZ","news_summary":"Haifa team IDs activity of proteins linked to memory loss","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":5,"techcommunityinvolvement":null,"mediagallery":[],"tags":["drug-discovery","pharmaceuticals","neurology","alzheimers-disease","therapeutics","patients","amyotrophic-lateral-sclerosis-(als)","seniors","neuroscience","degenerative-diseases","parkinson","rare-diseases","inflammatory-diseases"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":[{"date":"2015-01-01","name":"Drug development for improving cognitive impairment","tags":["pharmaceuticals"],"category":"Pharmaceuticals & Diagnostics","tto_logo":"/image_cloud/carmel_tto_logo_e4472170-6016-11e8-b7f6-41fdcbb0dda6","university_logo":"/image_cloud/carmel_institution_logo_e4472170-6016-11e8-b7f6-41fdcbb0dda6"},{"date":"2015-12-01","name":"Enhancing long-term memory","tags":["neurology","drug-discovery"],"category":"Pharmaceuticals & Diagnostics","tto_logo":"/image_cloud/carmel_tto_logo_e4472170-6016-11e8-b7f6-41fdcbb0dda6","university_logo":"/image_cloud/carmel_institution_logo_e4472170-6016-11e8-b7f6-41fdcbb0dda6"}],"usecases":[],"businessmodels":["B2B"],"productstage":"R&D","products":["PKR Inhibitor"],"geomarkets":["Asia","United States","Europe"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":10,"lastfunding":"$3.6M","totalrounds":4,"fundingstage":"Seed","totalfunding":"$13.85M","publicinvestors":4,"lastpublicfunding":2250000,"totalpublicrounds":1,"totalpublicfunding":2250000},"team":[{"name":"Yotam Nisemblat","email":"yotam@protektx.com","phone":"","gender":"Male","userid":"w99phANljksIie74rp1aoNJyMTlw3la21GQSFHA68TGv8TcczbdpeC","bounced":false,"claimed":1,"founder":0,"urlname":"yotam-nisemblat-1","visible":1,"memberid":"rvi8Y5x9nKwq4mnHJ4SxINLa7PyzsB5Agyx3X8RPsUO5lH8UzXeEHe","position":"CEO","last_name":"Nisemblat","claimtoken":"3Y9zakzO4sBOYC1ax0Y2Z1dStTAYrmmBWy1mpPIZ7UMOGwa6CQgwR3","first_name":"Yotam ","picturekey":null,"claimeddate":"2024-03-25","linkedinurl":"https://linkedin.com/in/yotam-nisemblat-07031977","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-21 13:42:35.000000","initials":"YN","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dalik Pinkert","email":"Dalik@protektx.com","phone":"","gender":"Female","userid":"bcK1BYRL8mRc2BZ70wynujMm8b1Oug7xBWBuPIOH56LY62hYLZdESu","bounced":false,"claimed":null,"founder":0,"urlname":"dalik-pinkert","visible":1,"memberid":"278yTfabkQvfjGMdXZWIG3tne5o5NyYccw6DXgpnDkDamIyQvvgrb6","position":"Senior Director of CMC and Medicinal Chemistry ","last_name":"Pinkert","claimtoken":null,"first_name":"Dalik","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/dalia-dalik-pinkert-phd/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"DP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Prof. Kobi Rosenblum","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4KrvtcgKDA","bounced":false,"claimed":0,"founder":1,"urlname":"prof-kobi-rosenblum","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg2qKK1wgM","position":"Investor","last_name":"Rosenblum","claimtoken":"467ffcd788f092280aeeb992f35022f3369e909122eff773368c5e67afa1c9d8","first_name":"Prof. Kobi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/kobi-rosenblum-b71345a/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2019-11-17 07:30:05.000000","initials":"PR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-04-03T00:00:00.000Z","crunchbaseid":"protekt-therapeutics","lastupdator":"Orli Wollner","lastupdator_email":"orlushka@gmail.com","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2016-08-03T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODK05y6CAw","date":"Nov 2019","amount":"$3.6M","source":"https://en.globes.co.il/en/article-israeli-co-protekt-therapeutics-raises-36m-1001307001","eventtype":"FundingRoundEvent","investment":[{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"02c2efd6-52b0-47a8-a362-d184e509775c","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "},{"name":"RMGP Biopharma Investment Fund","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/rmgp-biopharma-investment-fund","logokey":"$y88zM0qBaollgBKVZMi3QBw3vrT0uqZI7fjjmNhl1ofBLm0l3DnQcp","tagline":null,"urlname":"/investor_page/rmgp-biopharma-investment-fund","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPn88cMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0f7b762b-c855-4a54-aae2-eb13df3d6770","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$y88zM0qBaollgBKVZMi3QBw3vrT0uqZI7fjjmNhl1ofBLm0l3DnQcp","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Takeda","type":"Multinational","amount":0,"hidden":false,"country":"Japan","fullurl":"/mnc_page/takeda","logokey":"$2HdbHpFWxsWf3QAG4Lc5sNnioW26PxHDc2IeFTCFgjjPOnaQOl7k6a","tagline":"Pharmaceuticals","urlname":"/mnc_page/takeda","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ojons4IDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"4a090cb1-9fc4-4d2b-8dac-15c5eda4a726","fundingsubtype":null,"investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2HdbHpFWxsWf3QAG4Lc5sNnioW26PxHDc2IeFTCFgjjPOnaQOl7k6a","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Fonds de Solidarit FTQ","type":"Other","amount":0,"hidden":false,"country":"Canada","fullurl":"/company_page/fonds-de-solidarit-ftq","logokey":"$ZT6urkCo4PM5IUqbtXHYZkhtR1YCsz7LunxTr7eodYDlCBOSmIHhQ8","tagline":"Development Capital Fund","urlname":"/company_page/fonds-de-solidarit-ftq","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCqsKqRCww","fundingtype":"Other","leadpartner":null,"investmentid":"5c05a25d-7e08-4e84-b8a7-703842e60422","fundingsubtype":"","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZT6urkCo4PM5IUqbtXHYZkhtR1YCsz7LunxTr7eodYDlCBOSmIHhQ8","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"FutuRx","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/futurx","logokey":"$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","tagline":null,"urlname":"/investor_page/futurx","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKP2oZIKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"76bc36b9-b127-4560-b470-7e34e0b5a47e","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Carmel Innovation Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/carmel-innovation-fund","logokey":"$r6cT4RPlny5MS7I9pEdQkj7UfF6WmOU2yoWdcEdjwO0Ma2bjygMvdl","tagline":null,"urlname":"/investor_page/carmel-innovation-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIm9hIALDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"pHJpvOYQDfOfG4vlbG3AMMQ8sbGYbPhSXkmUuarHY2t3lvyur6v9Sq","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$r6cT4RPlny5MS7I9pEdQkj7UfF6WmOU2yoWdcEdjwO0Ma2bjygMvdl","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Private\n
'","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":3600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEqNqnCAw","date":"May 2017","amount":"$8M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"04c8507f-01ef-49b3-9ac9-69dc224f2992","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","leadcaption":"","followupcaption":"Follow on "},{"name":"Johnson & Johnson Innovation","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/johnson-johnson-development-corporation","logokey":"$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","tagline":null,"urlname":"/investor_page/johnson-johnson-development-corporation","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwITBs4MKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"1a3ab74f-3170-425c-b3d9-5554ba5097a5","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","leadcaption":"","followupcaption":"Follow on "},{"name":"Pontifax","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/Pontifax","logokey":"$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","tagline":null,"urlname":"/investor_page/Pontifax","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOfWjoAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"7874f10d-d626-4f49-b2f9-3008178e26ef","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","leadcaption":"","followupcaption":""},{"name":"Takeda Ventures","type":"Investor","amount":0,"hidden":false,"country":"Japan","fullurl":"/investor_page/takeda-ventures","logokey":"$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","tagline":null,"urlname":"/investor_page/takeda-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NWZ7KkIDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"7c373a64-13c7-4a61-86b9-845d1ae65e22","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Internal","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Internal\n
'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCWtq6pCAw","hub":"FutuRx","date":"Dec 2015","batch":"","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKP2oZIKDA","source":"https://www.futurx.co.il/portfolio/protekt-therapeutics/","enddate":"","hub_type":"Investor","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/investor_page/futurx","hub_logokey":"$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","hub_urlname":"/investor_page/futurx","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1c6vCAw","date":"Dec 2015","amount":"$2.25M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"14e79b8e-8eb2-4720-9f76-5e9e841c46d1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","leadcaption":"","followupcaption":""},{"name":"Johnson & Johnson Innovation","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/johnson-johnson-development-corporation","logokey":"$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","tagline":null,"urlname":"/investor_page/johnson-johnson-development-corporation","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwITBs4MKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"2722b229-a048-4a8f-aac3-4ea268534d99","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","leadcaption":"","followupcaption":""},{"name":"Takeda Ventures","type":"Investor","amount":0,"hidden":false,"country":"Japan","fullurl":"/investor_page/takeda-ventures","logokey":"$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","tagline":null,"urlname":"/investor_page/takeda-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NWZ7KkIDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"bec21a8d-f156-48d8-9b27-c366a57d44f9","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"f9dbd566-4160-43a3-970e-59fa61bf37e1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2250000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvPOICAw","date":"Jan 2015","amount":"Undisclosed","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":1,"investment":[{"name":null,"type":null,"amount":0,"hidden":false,"country":"Israel","fullurl":null,"logokey":null,"tagline":null,"urlname":null,"isisraeli":null,"investorid":null,"fundingtype":"Angel","leadpartner":null,"investmentid":"eac6dc9f-94c7-4e9b-a8df-4afeeac60cd0","fundingsubtype":null,"investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/empty-state.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Private","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Private\n
'","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/2014","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Protekt Therapeutics ","logourl":"https://storage.googleapis.com/clean-finder-353810/$PUC7R9TDFPF3OWeavgoDg0BM7Cm0A86pfcVq05rYY1jqIa8S27qERK.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$PUC7R9TDFPF3OWeavgoDg0BM7Cm0A86pfcVq05rYY1jqIa8S27qERK.png","seoabout":"Protekt Therapeutics is a biopharmaceutical company aiming to identify and develop a potent and selective oral PKR inhibitor (PKRi) to treat cognitive diso...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]},{"title":"Healthcare","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Healthcare","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODK05y6CAw","date":"Nov 2019","amount":"$3.6M","source":"https://en.globes.co.il/en/article-israeli-co-protekt-therapeutics-raises-36m-1001307001","eventtype":"FundingRoundEvent","investment":[{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"02c2efd6-52b0-47a8-a362-d184e509775c","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on "},{"name":"RMGP Biopharma Investment Fund","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/rmgp-biopharma-investment-fund","logokey":"$y88zM0qBaollgBKVZMi3QBw3vrT0uqZI7fjjmNhl1ofBLm0l3DnQcp","tagline":null,"urlname":"/investor_page/rmgp-biopharma-investment-fund","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPn88cMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0f7b762b-c855-4a54-aae2-eb13df3d6770","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$y88zM0qBaollgBKVZMi3QBw3vrT0uqZI7fjjmNhl1ofBLm0l3DnQcp","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Takeda","type":"Multinational","amount":0,"hidden":false,"country":"Japan","fullurl":"/mnc_page/takeda","logokey":"$2HdbHpFWxsWf3QAG4Lc5sNnioW26PxHDc2IeFTCFgjjPOnaQOl7k6a","tagline":"Pharmaceuticals","urlname":"/mnc_page/takeda","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ojons4IDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"4a090cb1-9fc4-4d2b-8dac-15c5eda4a726","fundingsubtype":null,"investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2HdbHpFWxsWf3QAG4Lc5sNnioW26PxHDc2IeFTCFgjjPOnaQOl7k6a","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Fonds de Solidarit FTQ","type":"Other","amount":0,"hidden":false,"country":"Canada","fullurl":"/company_page/fonds-de-solidarit-ftq","logokey":"$ZT6urkCo4PM5IUqbtXHYZkhtR1YCsz7LunxTr7eodYDlCBOSmIHhQ8","tagline":"Development Capital Fund","urlname":"/company_page/fonds-de-solidarit-ftq","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCqsKqRCww","fundingtype":"Other","leadpartner":null,"investmentid":"5c05a25d-7e08-4e84-b8a7-703842e60422","fundingsubtype":"","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZT6urkCo4PM5IUqbtXHYZkhtR1YCsz7LunxTr7eodYDlCBOSmIHhQ8","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"FutuRx","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/futurx","logokey":"$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","tagline":null,"urlname":"/investor_page/futurx","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKP2oZIKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"76bc36b9-b127-4560-b470-7e34e0b5a47e","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Carmel Innovation Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/carmel-innovation-fund","logokey":"$r6cT4RPlny5MS7I9pEdQkj7UfF6WmOU2yoWdcEdjwO0Ma2bjygMvdl","tagline":null,"urlname":"/investor_page/carmel-innovation-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIm9hIALDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"pHJpvOYQDfOfG4vlbG3AMMQ8sbGYbPhSXkmUuarHY2t3lvyur6v9Sq","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":null,"isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$r6cT4RPlny5MS7I9pEdQkj7UfF6WmOU2yoWdcEdjwO0Ma2bjygMvdl","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Private\n
'","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":3600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEqNqnCAw","date":"May 2017","amount":"$8M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"04c8507f-01ef-49b3-9ac9-69dc224f2992","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","leadcaption":"","followupcaption":"Follow on "},{"name":"Johnson & Johnson Innovation","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/johnson-johnson-development-corporation","logokey":"$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","tagline":null,"urlname":"/investor_page/johnson-johnson-development-corporation","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwITBs4MKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"1a3ab74f-3170-425c-b3d9-5554ba5097a5","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","leadcaption":"","followupcaption":"Follow on "},{"name":"Pontifax","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/Pontifax","logokey":"$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","tagline":null,"urlname":"/investor_page/Pontifax","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOfWjoAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"7874f10d-d626-4f49-b2f9-3008178e26ef","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","leadcaption":"","followupcaption":""},{"name":"Takeda Ventures","type":"Investor","amount":0,"hidden":false,"country":"Japan","fullurl":"/investor_page/takeda-ventures","logokey":"$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","tagline":null,"urlname":"/investor_page/takeda-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NWZ7KkIDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"7c373a64-13c7-4a61-86b9-845d1ae65e22","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Internal","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Internal\n
'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1c6vCAw","date":"Dec 2015","amount":"$2.25M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"OrbiMed","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/orbimed","logokey":"$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","tagline":null,"urlname":"/investor_page/orbimed","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKGWppMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"14e79b8e-8eb2-4720-9f76-5e9e841c46d1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YdYRiJO5uDKRYVV4ljtlt361skiLJyDfu6DOVXBmeHHKhWCPE7itwN","leadcaption":"","followupcaption":""},{"name":"Johnson & Johnson Innovation","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/johnson-johnson-development-corporation","logokey":"$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","tagline":null,"urlname":"/investor_page/johnson-johnson-development-corporation","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwITBs4MKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"2722b229-a048-4a8f-aac3-4ea268534d99","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4EccGeA7CnODtuJfuXZHm6rgAKVHb8UpRtVyqZSCmQ4mKkYeHPeURP","leadcaption":"","followupcaption":""},{"name":"Takeda Ventures","type":"Investor","amount":0,"hidden":false,"country":"Japan","fullurl":"/investor_page/takeda-ventures","logokey":"$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","tagline":null,"urlname":"/investor_page/takeda-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NWZ7KkIDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"bec21a8d-f156-48d8-9b27-c366a57d44f9","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$KF0xFRFBu3GhEyU6Rbs1uLNSoAH4QN1V02b6iNzoHXbS5px8PQ2Q4F","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"f9dbd566-4160-43a3-970e-59fa61bf37e1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2250000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvPOICAw","date":"Jan 2015","amount":"Undisclosed","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":1,"investment":[{"name":null,"type":null,"amount":0,"hidden":false,"country":"Israel","fullurl":null,"logokey":null,"tagline":null,"urlname":null,"isisraeli":null,"investorid":null,"fundingtype":"Angel","leadpartner":null,"investmentid":"eac6dc9f-94c7-4e9b-a8df-4afeeac60cd0","fundingsubtype":null,"investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/empty-state.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Private","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Private\n
'","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}